Glycomet Trio 0.5 Tablet

Composition

Glimepiride 0.5 mg + Metformin Hydrochloride 500 mg (sustained release) + Voglibose 0.2 mg

Uses of Glycomet Trio 0.5 Tablet

Type 2 diabetes mellitus in adults when blood glucose is not adequately controlled with diet/exercise and/or dual therapy; helps control fasting and post-meal blood sugar

• •Controls fasting and post-meal blood sugar
• •Improves insulin sensitivity and reduces hepatic glucose output
• •Reduces carbohydrate absorption and post-meal spikes
• •Helps lower HbA1c when dual therapy is insufficient

How it works

Metformin reduces glucose production in the liver and improves insulin sensitivity. Glimepiride stimulates the pancreas to release insulin. Voglibose slows carbohydrate digestion/absorption in the intestine, reducing post-meal blood sugar spikes.

Directions for use

Tablet (oral). Take exactly as prescribed, usually once daily with/after meals (often with the first main meal) to reduce stomach upset and hypoglycaemia. Swallow whole with water; do not crush/chew sustained-release tablets. Follow diet and exercise advice and monitor blood glucose regularly.

Side effects

Common side effects of Glycomet Trio 0.5 Tablet may include:

• •Hypoglycaemia
• •nausea
• •vomiting
• •diarrhoea